All STRATEGY IS LOCAL True competitive advantages are harder to find and maintain than people realize. The odds are best in tightly drawn markets‚ not big‚ sprawling ones. "STRATEGIC" IS THE MOST OVERUSED WORD in the vocabulary of business. Frequently it’s just another way of saying‚ "This is important" The reality is that there are only a few situations in which companies’ strategies affect outcomes. Such situations are‚ however‚ worth trying to create since the alternative‚ achieving superior
Premium Rate of return Marketing Telephone company
Corporate Social Responsibility: What Went Wrong at GlaxoSmithKline? When London-based GlaxoSmithKline (GSK) paid a $750 million dollar settlement as part of a plea agreement that required it’s Cidra‚ Puerto Rico subsidiary SB Pharmco to plead guilty for knowingly selling contaminated medicine‚ it laid to rest any doubts that its business practices were in direct conflict with its commitment to both quality and to creating a strong ethical culture. There are‚ nevertheless‚ important issues
Premium Management Pharmacology Food and Drug Administration
VISION To be preferred provider of quality and affordable healthcare solutions in the region. MISSION To provide our partners truly affordable and quality healthcare solutions • PATIENT To make our products and services available to majority of households. • DOCTORS AND ALLIED PROFESSIONALS To enrich the profession of our partners in the medical community by helping them achieve patient compliance. • TRADE To build lasting‚ productive and value adding partnership by contributing to their
Premium Generic drug Pharmaceutical industry Pharmacology
Interview Process At Ranbaxy R.P. Report Compiled By: Aditi Apoorva Nayan Swati Shivani Under the Guidance of Prof. N.N.Akhouri Ranbaxy Laboratories Limited: Ranbaxy is one of India ’s largest pharmaceutical companies. Incorporated in 1961‚ Ranbaxy exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. The company went public in 1973‚ and Japanese company Daiichi Sankyo gained majority control in 2008. Milestones
Premium Ranbaxy Laboratories Generic drug Recruitment
FDA Drug Approval Process Tricia Garbuzovas COM/172 October 5‚ 2011 Cassandra Baker FDA Drug Approval Process Americans must wait up to 19 years after a discovered treatment before they can participate in benefits of a new medication (Philipson & Sun‚ 2008). The regulatory process drug manufacturers need to endure before releasing potentially life-saving medication is an extremely expensive‚ time-consuming process. The Center for Drug Evaluation and Research (CDER) is the main department
Premium Food and Drug Administration Pharmacology Pharmaceutical industry
Dumping is wrong‚ even if there is no law broken. I know this is a matter of opinion‚ however I believe dumping is immoral even if there is no way to objectively determine it. I guess it could be possible to argue that there is nothing wrong with dumping. Companies within the United States often sell their goods at prices that are below the cost of production. And at times if their products are outlawed and unable to be sold in the United States‚ I understand that they are trying to salvage some
Premium Ethics United States Drug addiction
results of the SWOT analysis Pfizer is a marketing partner of choice for medium and small pharmaceutical companies to commercialize their products (Market Line‚ 2013‚ p. 25). Health care cost containment pressures could affect the company’s top-line growth (Market Line‚ 2013‚ p. 25). Strengths in Pfizer’s favor are big ticket deals with M&A to sustain the leadership position‚ acquiring King Pharmaceuticals‚ and developing stronger commercials. Developing these strengths help give Pfizer the leading
Premium Health care Pharmaceutical industry
payment and future royalties avoiding any large capital investment in manufacturing‚ enabling the company to concentrate solely on R&D. Licensing at this early stage would inevitably generate much lower revenues‚ but in addition to that‚ the industry specific circumstances in producing and scaling up complex processes in genetically engineered drugs there would be another consideration against being solely an R&D laboratory. Cloning a molecule in an R&D environment is a long way from
Premium Clinical trial Drug discovery Pharmaceutical industry
the “Ceredase” drug- to treat the Gaucher`s disease. It was sold to over 4000 patients‚ with annual revenue of 800 million dollars. They had different way of manufacturing and sales compare to other companies. They did not do licensing to large pharmaceutical company. Genzyme was the worlds third largest biotech company in 2006 only profiting of rare diseases. Reflection of the case * Avoided “blockbuster” market and good management Good strategic to focus on a niche market instead of the ”blockbuster”
Premium Pharmacology Pharmaceutical drug Biotechnology
regulated FDA guidelines that are needed to guarantee medicines are in fact safe for the consumers. I do not feel anything can be done regarding regulations that are set for patient safety. Yes‚ drug prices reflect a fair and competitive market. Pharmaceutical companies are in the business to provide treatment/cures to diseases that were considered killers just a few years ago. The high cost is misinterpreted as a greed endeavor. However‚ what the public fails to understand is that for every ten projects
Premium Pharmacology Pharmaceutical industry Generic drug